IMCAS Bali 2019
IMCAS (International Master Course on Aging Sciences) is dedicated to achieving the highest quality of teaching through the interface of plastic surgery and dermatology. IMCAS has become one of the most important international courses dedicated to aging skin treatments. There are 104 scientific sessions covering the most recent developments in 15 key themes, which include face, breast & body surgery, clinical dermatology, peelings, genital treatments, hair restoration, regenerative medicine and lipofiling, lasers & EBD. This IMCAS held on July, 5-7th, 2019 at The Westin Resort Nusa Dua Bali, Indonesia.
Nabota (Natural Botulinum toxin Type A) was developed with Daewoong’s 30 years of experience in Biotechnology. Nabota ensures the quality of international standards via its own patented purification process (patented registration KR-10 1339349 patented in 2013). Nabota is highly purified product manufactured with a patented purification process from which impurities are removed as much as possible. Excellence in quality of Nabota has led to contracts the finished product to about 90 countries including the United States and 28 European country. Nabota has more than 98% purity resulted from Hi-Pure purification technology, and it is officially approved by FDA on February 2019. Nabota has completed phase III in US FDA, EU EMEA and Canada, which proven efficacy & safety with clinical studies over 2,000 patients.
Daewoong Symposium at IMCAS
During the IMCAS, Nabota has symposium which have a theme Global Perspectives on New Botulinum Toxin: Advancing Result, Safety and New Injection Technique Based on Anatomy with the speaker Dr. Hema Sundaram (Dermatologist from USA), Pr. Seungho Han (Anatomist from Korea), Dr. Wonwoo Choi (Dermatologist from Korea). Beside the symposium, we also had 15-min Industry Lecture in open stage with speaker Pr. Seongtaek Kim with the theme Application of Nabota in Bruxism and Tempromandibular Disorder (TMD) Treatment, and we also had Pr. Seungho Han who speak about Botulinum toxin Injection: Upper Face Anatomy to avoid Side Effects.
Nabota Aesthetic Forum (NAF)
Nabota Aesthetic Forum (NAF) held on July, 6th, 2019 at The Grand Hyatt Nusa Dua, Bali. It was participated by 19 doctors (3 doctors from Thailand, 1 doctor from Vietnam, 7 doctors from Philippine, 4 doctors from Indonesia, and 5 doctors from Korea). We had 9 sessions on NAF, which are NABOTA: Injection for shoulder contouring and sleep bruxism; clinical trials by Prof. Seongtaek Kim, Combining Surgical and Non-surgical Modalities for Jaw Contouring – Indian Scenario by Dr. Viral Ramesh Desai (Plastic Surgeon, India), Nabolift Injection Techniques by Dr. Wonwoo Choi (Wells Dermatology Clinic, Korea), Consideration on Botox Antibody Formation by Dr. Hyungseok Ko (Samsunglohas Clinic, Korea), Strong Efficacy of Nabota, Clinical Studies and Result in Vietnam by Dr. Pham Xuan Hung (Plastic Surgeon, Vietnam).
In the night session we had Botulinum Toxin Injection; Upper Face Anatomy to Avoid Side Effects by Prof. Seongho Han (Chung-Ang Univ, Korea), Comparison of Botulinum Toxin; Preliminary Study by Dr. Minchul Kang (Centrum Ryn Clinic, Korea), Lip Filler with Botulinum Toxin for Perioral Rhytides by Dr. Jaeun Doh (EG Dong An Clinic, Korea), Paradoxical Massetheric bulging after Botulinum Toxin injection: Basis and Prevention by Dr. Ruecha Rassamechote (Dermatologist Thailand). After the closing we had dinner together with participant and speaer doctors and also Daewoong staff at Pasar Senggol, Grand Hyatt, Bali.
